Clearly, the activation of EMT, especially through the upregulation of N-cadherin, Vimentin and Fibronectin by the suppression of miR-598-3p, have been shown to make a great contribution to gastric cancer metastasis in vitro and in vivo. The gene discussed is CDH2; the disease is gastric cancer.